STOCK TITAN

iShares Biotechnology ETF Stock Price, News & Analysis

IBB NASDAQ

Company Description

iShares Biotechnology ETF (NASDAQ: IBB) is a publicly traded company. The company has a market capitalization of $12.3B.

IBB stock has gained 49.9% over the past year, placing it at #2,166 in year-to-date performance among tracked companies. Shares last traded at $175.76.

This page provides a comprehensive overview of IBB stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$175.81
-0.48%
0.85
Last updated: April 20, 2026 at 15:59
+49.91%
Performance 1 year
$12.3B

iShares Biotechnology ETF (IBB) stock last traded at $175.76, down 0.48% from the previous close. Over the past 12 months, the stock has gained 49.9%. At a market capitalization of $12.3B, IBB is classified as a large-cap stock with approximately 49.0M shares outstanding.

Latest News

iShares Biotechnology ETF has 2 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 0 with negative movement. View all IBB news →

SEC Filings

iShares Biotechnology ETF has filed 1 recent SEC filing, including 1 Form 13F-NT. The most recent filing was submitted on August 12, 2025. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all IBB SEC filings →

Financial Highlights

Revenue (TTM)
Net Income (TTM)
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Short interest in iShares Biotechnology ETF (IBB) currently stands at 13.3 million shares, down 7.1% from the previous reporting period, representing 27.1% of the float. Over the past 12 months, short interest has increased by 19.5%. This high level of short interest suggests significant bearish sentiment among traders. The 7.8 days to cover indicates moderate liquidity for short covering.

Days to Cover History

Last 12 Months

Days to cover for iShares Biotechnology ETF (IBB) currently stands at 7.8 days. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The ratio has shown significant volatility over the period, ranging from 4.1 to 9.8 days.

Frequently Asked Questions

What is the current stock price of iShares Biotechnology ETF (IBB)?

The current stock price of iShares Biotechnology ETF (IBB) is $175.76 as of April 20, 2026.

What is the market cap of iShares Biotechnology ETF (IBB)?

The market cap of iShares Biotechnology ETF (IBB) is approximately 12.3B. Learn more about what market capitalization means .